4BM
N-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide
Find entries where: 4BM
is present as a standalone ligand in 5 entries
Chemical Component Summary | |
---|---|
Name | N-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide |
Identifiers | N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodo-phenyl)amino]benzamide |
Formula | C16 H14 F3 I N2 O4 |
Molecular Weight | 482.193 |
Type | NON-POLYMER |
Isomeric SMILES | c1cc(c(cc1I)F)Nc2c(ccc(c2F)F)C(=O)NOC[C@@H](CO)O |
InChI | InChI=1S/C16H14F3IN2O4/c17-11-3-2-10(16(25)22-26-7-9(24)6-23)15(14(11)19)21-13-4-1-8(20)5-12(13)18/h1-5,9,21,23-24H,6-7H2,(H,22,25)/t9-/m1/s1 |
InChIKey | SUDAHWBOROXANE-SECBINFHSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 40 |
Chiral Atom Count | 1 |
Bond Count | 41 |
Aromatic Bond Count | 12 |
Drug Info: DrugBank
DrugBank ID | DB07101 |
---|---|
Name | Mirdametinib |
Groups | investigational |
Description | PD-0325901 has been used in trials studying the treatment and basic science of Melanoma, Solid Tumour, Solid Tumors, Advanced Cancer, and Breast Neoplasms, among others. |
Synonyms |
|
Categories |
|
CAS number | 391210-10-9 |
Drug Targets
Name | Target Sequence | Pharmacological Action | Actions |
---|---|---|---|
Dual specificity mitogen-activated protein kinase kinase 1 | MPKKKPTPIQLNPAPDGSAVNGTSSAETNLEALQKKLEELELDEQQRKRL... | unknown |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
Resource Name | Reference |
---|---|
Pharos | CHEMBL507361 |
PubChem | 9826528 |
ChEMBL | CHEMBL507361 |
ChEBI | CHEBI:88249 |